Scaling up Regeneron's antibody treatment is not an easy task, as it requires clinical trials to determine the right way to treat and protect people from anaphylactic shock caused by an allergic reaction to the foreign antibody. The trials have been ongoing since March, and Regeneron likely administered Benadryl and a steroid shot to Trump when he received the treatment.